chlorazanil 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
591 500-42-5

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • chlorazanil hydrochloride
  • chlorazanil
  • chlorazinil
  • chloroazinal
  • diurazine
  • diurazyna
  • neurofort
  • orpizin
  • triazurol
  • chlorazanil HCl
  • Molecular weight: 221.65
  • Formula: C9H8ClN5
  • CLOGP: 2.33
  • LIPINSKI: 0
  • HAC: 5
  • HDO: 2
  • TPSA: 76.72
  • ALOGS: -3.08
  • ROTB: 2

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
kinase-safety-class ACVR2A,ACVR2B,ALK,AURKA,AURKB,AXL,BRAF,CAMK2B,CAMK2D,CDK1,CDK2,CDK5,CDK9,CHEK1,CLK4,CSF1R,DDR1,DYRK1B,EGFR,EIF2AK3,EPHA2,EPHB4,ERBB2,FLT3,GRK2,IRAK1,IRAK3,ITK,JAK1,JAK2,MAP3K1,MAP3K10,MAP3K21,MAP4K1,MAP4K3,MAPK1,MAPK12,MAPK7,MAPK9,MARK4,MET,MKNK1,MKNK2,MTOR,NTRK1,NTRK2,PAK4,PDK2,PDK4,PIK3CG,PIM2,PRKCD,PRKDC,SGK1,SIK2,SIK3,STK10,STK33,SYK,TEK,TTK,ULK1,ULK2 63
kinase-selectivity-class ACVR2A,AURKA,BRAF,CAMK2D,CDK1,CDK9,FLT3,JAK1,MAP2K3,MAP3K10,MAP3K21,MAPK7,SIK2,SIK3,TTK 15
pfas-class PFAS structural alert (1 = True, 0 = False) 0

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

None

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Pernicious anemia indication 84027009 DOID:13381
Cobalamin deficiency indication 190634004
Prevention of Vitamin B12 Deficiency indication
Methylmalonic acidemia off-label use 42393006
Hypokalemia contraindication 43339004
Leber's optic atrophy contraindication 58610003 DOID:705




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 4.24 Basic
pKa2 1.15 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
2019-25-2 SECONDARY_CAS_RN
C0055343 UMLSCUI
CHEBI:134911 CHEBI
CHEMBL1984344 ChEMBL_ID
CHEMBL2104101 ChEMBL_ID
10374 PUBCHEM_CID
C017837 MESH_SUPPLEMENTAL_RECORD_UI
724 INN_ID
48SN4K3W0E UNII
88802007 SNOMEDCT_US

Pharmaceutical products:

None